Mai Fujiwara was selected for an oral presentation at the Federation of Clinical Immunology Societies (FOCIS) 2016 meeting in Boston on Friday, June 24th. Her presentation focused on a topic with potentially important therapeutic implications in cancer immunotherapy – the relationship between Cbl-b deficiency and resistance of T cells and NK cells to PD-L1/PD-1 regulation.
